Stock listing
gettex:4LN2 Capricor Therapeutics, Inc. Aktie
German listing (gettex) of Capricor Therapeutics, Inc. · home listing NASDAQ:CAPR
Follow Capricor Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CAPR
$6.65 USD -0.06 (-0.9%)
Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CAPR
- Day range
- $6.54 – $6.93 USDOct 19, 2026
- Volume
- 1.91M sharesOct 19, 2026
- Market cap
- $386.6M USDAt the close on Oct 19, 2026 · price × 58.14M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CAPR · Home | $6.65 USD | -0.06 (-0.9%) | 1,911,188 | $6.82 | $6.925 | $6.54 | $6.71 | Close on Oct 19, 2026 |
| Frankfurt:4LN2 | €5.948 EUR | -0.29 (-4.6%) | — | €5.884 | €5.948 | €5.88 | €6.238 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:CAPR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $6.65 | -0.06 | -0.9% | $6.82 | $6.925 | $6.54 | 1,911,188 | |
| $6.71 | -0.56 | -7.7% | $7.21 | $7.25 | $6.68 | 1,920,127 | |
| $7.27 | +0.68 | +10.3% | $6.64 | $7.33 | $6.64 | 3,351,295 | |
| $6.59 | -0.29 | -4.2% | $6.76 | $6.89 | $6.47 | 2,509,800 | |
| $6.88 | -0.59 | -7.9% | $7.32 | $7.40 | $6.87 | 2,617,302 | |
| $7.47 | -0.36 | -4.6% | $7.79 | $7.81 | $7.45 | 1,456,800 | |
| $7.83 | -0.18 | -2.2% | $8.01 | $8.05 | $7.69 | 1,694,100 | |
| $8.01 | -0.09 | -1.1% | $7.89 | $8.17 | $7.80 | 2,513,400 | |
| $8.10 | +0.35 | +4.5% | $7.59 | $8.27 | $7.46 | 2,885,500 | |
| $7.75 | -0.03 | -0.4% | $7.75 | $7.89 | $7.46 | 3,127,100 | |
| $7.78 | -1.17 | -13.1% | $8.75 | $8.80 | $7.37 | 6,771,900 | |
| $8.95 | +0.01 | +0.1% | $9.14 | $9.24 | $8.77 | 2,639,000 | |
| $8.94 | -0.53 | -5.6% | $9.36 | $9.39 | $8.83 | 3,875,900 | |
| $9.47 | +0.90 | +10.5% | $10.03 | $10.72 | $9.40 | 20,566,600 | |
| $8.57 | -0.14 | -1.6% | $8.75 | $8.97 | $8.50 | 2,674,700 | |
| $8.71 | +0.35 | +4.2% | $8.29 | $8.84 | $8.15 | 2,089,900 | |
| $8.36 | -0.21 | -2.5% | $8.61 | $8.67 | $8.30 | 1,910,900 | |
| $8.57 | -0.10 | -1.2% | $8.60 | $8.87 | $8.27 | 2,399,800 | |
| $8.67 | -0.67 | -7.2% | $9.26 | $9.36 | $8.52 | 3,139,200 | |
| $9.34 | +0.44 | +4.9% | $9.01 | $9.48 | $8.89 | 2,496,800 | |
| $8.90 | -0.16 | -1.8% | $9.14 | $9.28 | $8.84 | 2,419,000 | |
| $9.06 | -0.36 | -3.8% | $9.30 | $9.36 | $8.96 | 3,246,900 | |
| $9.42 | +0.86 | +10.0% | $8.93 | $9.79 | $8.82 | 3,937,500 | |
| $8.56 | 0.00 | 0.0% | $8.58 | $9.07 | $8.41 | 2,380,600 | |
| $8.56 | -0.25 | -2.8% | $8.83 | $8.90 | $8.38 | 2,172,300 | |
| $8.81 | +0.44 | +5.3% | $9.11 | $9.24 | $8.71 | 2,903,900 | |
| $8.37 | +0.07 | +0.8% | $8.32 | $8.67 | $8.26 | 2,070,400 | |
| $8.30 | -0.34 | -3.9% | $8.58 | $8.70 | $8.18 | 2,912,200 | |
| $8.64 | -0.42 | -4.6% | $9.08 | $9.27 | $8.60 | 2,750,700 | |
| $9.06 | -0.34 | -3.6% | $9.15 | $9.49 | $8.81 | 2,727,200 | |
| $9.40 | +0.12 | +1.3% | $9.40 | $9.81 | $9.26 | 2,555,700 | |
| $9.28 | -0.61 | -6.2% | $9.83 | $9.93 | $9.14 | 4,056,300 | |
| $9.89 | -0.12 | -1.2% | $10.07 | $10.65 | $9.60 | 5,156,100 | |
| $10.01 | +0.10 | +1.0% | $10.77 | $11.00 | $9.85 | 6,308,600 | |
| $9.91 | +0.32 | +3.3% | $9.50 | $10.27 | $9.07 | 4,558,800 | |
| $9.59 | -0.47 | -4.7% | $9.73 | $10.20 | $9.47 | 5,186,500 | |
| $10.06 | +0.70 | +7.5% | $9.19 | $10.61 | $8.90 | 12,045,600 | |
| $9.36 | +1.07 | +12.9% | $8.29 | $9.88 | $8.05 | 12,037,100 | |
| $8.29 | +1.49 | +21.9% | $7.25 | $8.60 | $7.25 | 17,634,400 | |
| $6.80 | +0.51 | +8.1% | $8.03 | $8.03 | $6.34 | 20,085,600 | |
| $6.29 | -0.55 | -8.0% | $6.81 | $7.08 | $6.01 | 8,361,100 | |
| $6.84 | -1.14 | -14.3% | $7.66 | $7.82 | $6.83 | 8,108,900 | |
| $7.98 | +0.90 | +12.7% | $7.19 | $7.99 | $7.14 | 8,565,500 | |
| $7.08 | -0.37 | -5.0% | $7.50 | $8.29 | $6.76 | 8,539,000 | |
| $7.45 | +0.80 | +12.0% | $6.87 | $7.59 | $6.59 | 19,218,800 | |
| $6.65 | +2.44 | +58.0% | $7.66 | $8.15 | $6.04 | 66,333,900 | |
| $4.21 | +0.02 | +0.5% | $4.18 | $4.42 | $4.14 | 16,749,500 | |
| $4.19 | +0.26 | +6.6% | $3.95 | $4.30 | $3.90 | 2,752,800 | |
| $3.93 | +0.08 | +2.1% | $3.85 | $4.00 | $3.73 | 3,331,700 | |
| $3.85 | -0.24 | -5.9% | $4.04 | $4.11 | $3.81 | 3,088,700 | |
| $4.09 | -0.09 | -2.2% | $4.16 | $4.70 | $4.05 | 3,618,200 | |
| $4.18 | +0.25 | +6.4% | $3.88 | $4.21 | $3.87 | 3,212,500 | |
| $3.93 | -0.24 | -5.8% | $4.16 | $4.31 | $3.85 | 3,678,200 | |
| $4.17 | -0.03 | -0.7% | $4.13 | $4.42 | $4.09 | 4,218,700 | |
| $4.20 | +0.35 | +9.1% | $3.78 | $4.20 | $3.66 | 5,167,000 | |
| $3.85 | -0.34 | -8.1% | $4.04 | $4.66 | $3.80 | 7,297,100 | |
| $4.19 | -2.38 | -36.2% | $3.07 | $4.21 | $2.96 | 28,916,900 | |
| $6.57 | 0.00 | 0.0% | $6.57 | $6.57 | $6.57 | 0 | |
| $6.57 | -0.43 | -6.1% | $6.78 | $7.22 | $5.67 | 16,545,700 | |
| $7.00 | -12.70 | -64.5% | $5.87 | $7.85 | $5.82 | 29,995,400 | |
| $19.70 | -0.13 | -0.7% | $19.77 | $20.18 | $18.31 | 2,469,800 | |
| $19.83 | +0.92 | +4.9% | $18.51 | $20.54 | $18.49 | 2,009,500 | |
| $18.91 | -0.88 | -4.4% | $19.72 | $19.92 | $18.77 | 1,544,900 | |
| $19.79 | +0.29 | +1.5% | $19.50 | $20.16 | $18.98 | 2,257,400 | |
| $19.50 | +0.06 | +0.3% | $19.68 | $20.17 | $18.93 | 1,911,500 |
- Ticker
- gettex:4LN2
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Oct 5, 2026
Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress
Latest earnings call · Aug 13, 2026
Capricor Therapeutics (NASDAQ:CAPR) Q2 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 38 slides
Calls
Replays
Capricor Therapeutics (NASDAQ:CAPR) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 4:30 PM ET
Watch TranscriptCapricor Therapeutics (NASDAQ:CAPR) Q1 2026 Earnings Call
Tue, May 12, 2026 · 4:30 PM ET
Watch TranscriptCapricor Therapeutics (NASDAQ:CAPR) Q4 2025 Earnings Call
Thu, Mar 12, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress
Oct 5, 2026
Closed $7.78 (-13.1%) on Oct 5, 2026
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
Sep 17, 2026
Closed $9.42 (+10.0%) on Sep 17, 2026
SHAREHOLDER REMINDER: Berger Montague Reminds Capricor Therapeutics, Inc. (CAPR) Investors of the September 28, 2026 Deadline
Sep 11, 2026
Closed $8.37 (+0.8%) on Sep 11, 2026
Issued by another party
Pomerantz LLP Issues Reminder to Investors in Capricor Therapeutics, Inc. of Class Action Filing - CAPR
Aug 27, 2026
Closed $10.06 (+7.5%) on Aug 27, 2026
Issued by another party
Capricor Therapeutics, Inc. (CAPR) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before September 28, 2026 Lead Plaintiff Deadline
Aug 25, 2026
Closed $9.36 (+12.9%) on Aug 26, 2026
Issued by another party
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Aug 24, 2026
Closed $6.80 (+8.1%) on Aug 24, 2026
Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
Aug 21, 2026
Closed $6.80 (+8.1%) on Aug 24, 2026
Pomerantz LLP Alerts Shareholders to Investor Suit Against Capricor Therapeutics, Inc. - CAPR
Aug 17, 2026
Closed $7.45 (+12.0%) on Aug 17, 2026
Issued by another party
Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 13, 2026
Closed $6.65 (+58.0%) on Aug 14, 2026
Capricor Therapeutics, Inc. (CAPR) Securities Fraud Investigation - Levi & Korsinsky
Aug 3, 2026
Closed $4.20 (+9.1%) on Aug 3, 2026
Issued by another party
Decks
Investor Presentation (August 2026)
Investor deck · 38 slides · August 2026
Q1 2026 Earnings Presentation
Earnings · 41 slides · May 12, 2026
Q4 2025 Earnings Presentation
Earnings · 20 slides · Mar 12, 2026
Corporate Update (December 2025)
Corporate update · 18 slides · Dec 3, 2025
Capricor Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 37 in the last 12 months · 185 in all · newest Oct 5, 2026 · oldest 2019
- Calls
- 24 calls with a replay · 24 with a transcript · latest Aug 13, 2026
- Decks
- 34 decks · latest August 2026
Where Capricor Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CAPR · Home listing | NASDAQ | United States | USD |
| gettex:4LN2 · This page | gettex | Germany | EUR |
| Tradegate:4LN2 | Tradegate | Germany | EUR |
| LS Exchange:A2PLU4 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2PLU4 | Lang & Schwarz | Germany | EUR |
| BOATS:CAPR | BOATS | United States | USD |
| Dusseldorf:4LN2 | Dusseldorf | Germany | EUR |
| Frankfurt:4LN2 | Frankfurt | Germany | EUR |
| Stuttgart:4LN2 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Capricor Therapeutics, Inc.